Who should pay for the continuity of post-trial health care treatments?

Abstract Background The bioethical debate in the world on who should pay for the continuity of post-trials treatment of patients that have medical indication remains obscure and introduces uncertainties to the patients involved in the trials. The continuity of post-trial treatment was only incorpora...

Descripció completa

Dades bibliogràfiques

Autors principals:	Roberto Iunes, Manuela Villar Uribe, Janet Bonilla Torres, Marina Morgado Garcia, Juliana Alvares-Teodoro, Francisco de Assis Acurcio, Augusto Afonso Guerra Junior
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2019-06-01
Col·lecció:	International Journal for Equity in Health
Matèries:	Equity Treatment of patients Post-trial access
Accés en línia:	http://link.springer.com/article/10.1186/s12939-019-0919-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!